Children of God for Life has provided the following science evidence which is recorded in the
vaccine manufacturer package inserts, science publications and patents
As early as 1936, forced abortions were performed under the US “Model Eugenic Sterilization Law” of 1922 and used in polio research. (Forsaking God for the Sake of Science) Quoting and referencing as follows:
Albert Sabin:
“A new approach was made by the use of 3- to 4-months-old human embryos, obtained aseptically by Cesarean section…The brain and cord, the lungs, kidneys, liver, and spleen were stored in the refrigerator, fragments of these tissues being taken for the preparation of media at 3-day intervals.” 1
Drs. Thicke, Duncan, Rhodes:
“Human embryos of two and one-half to five months gestation were obtained from the gynaecological
department of the Toronto General Hospital…No macerated specimens were used and in many of the embryos the heart was still beating at the time of receipt in the virus laboratory.” 2
Dr Enders, Weller, et al Nobel Prize for polio research:
“Embryos of between 12-18 weeks gestation have been utilized. Rarely tissues were obtained from stillborn fetuses, or from premature infants at autopsy…In the experiments 3 sorts of embryonic materials were used:
elements of skin, connective tissue, muscle; intestinal tissue; brain tissue…Whenever possible the embryo was emoved from the amniotic sac.., transferred to a sterile towel and kept at 5 C until dissected.”3
———————————————————————————–
RA273: Rubella Virus used in Rubella and MMR vaccines 4
– R=Rubella, A=Abortion, 27=27th aborted baby, 3=3rd Tissue where virus was isolated
– 6 weeks gestation; sex not recorded
– Isolated from kidney by Dr. Stanley Plotkin
– 40 more elective abortions for rubella virus isolation by T.H. Chang, 5 (67 total) *
WI-38: Wistar Institute, Specimen No. 38, 32nd Abortion 6, 7
– Abortion performed in Sweden and shipped to Leonard Hayflick, Wistar Institute, Philadelphia
– Lung tissue 3 months gestation female
– Used to culture RA273 for rubella and MMR vaccines *
* NOTE: 67 abortions to produce rubella virus plus 32 abortions to produce the cell line for cultivation means there was a total of at least 99 elective abortions to create the rubella vaccine alone.
WI-26: Wistar Institute, Specimen No. 26, 20th Abortion 8
– Abortion performed in Sweden and shipped to Leonard Hayflick, Wistar Institute, Philadelphia
– 3 months gestation male
– Lung Tissue
– Used in recombinant DNA for Enbrel
WI-44: Wistar Institute, Specimen No. 44, 38th Abortion 9
– Abortion performed in Sweden and shipped to Leonard Hayflick, Wistar Institute, Philadelphia
– 3 months gestation female
– Lung tissue
Dr Stanley Plotkin – open testimony on use of 76 aborted fetuses, 10
MRC-5: Medical Research Council, Abortion No. 5 11
– Abortion performed in UK for “psychiatric reasons”
– Lung Tissue, 14 weeks gestation male
– Used in (some) Polio, Rabies, Chickenpox, Hepatitis-A, Zostavax for shingles vaccines
HEK-293: Human Embryonic Kidney, Specimen No. 293 12
– Abortion performed in Netherlands
– Kidney Tissue; Gestation age not recorded
– Used in drugs, Pulmozyme, Repro, Eloctate, rhFVI, Nuwiq and Ebola vaccines under development
IMR-90: Abortion in US; Coriell Cell Repository, 13
– Designer cell line to replace WI-38
– 16 weeks gestation female
– Lung Tissue
IMR-91: Abortion in US; Coriell Cell Repository, 14
– Designer cell line to replace MRC-5
– 12 weeks gestation male
– Lung Tissue
Lambda.hE1: Abortion in US for “psychosocial indications” 15
– Second Trimester abortion
– Liver Tissue
– Used in drugs Procrit, Epoetin alfa, Epogen, Aranesp, Darbepoetin alfa
PER C6: Abortion in Netherlands, “mother wanted to get rid of the fetus, father unknown” 16
– 18 weeks gestation
– Retinal tissue
– Designed specifically for the pharmaceutical industry; Used in Ebola vaccines under development
WALVAX2: Abortion in China, 9th Abortion 17
– 3 months gestation female
– Lung tissue
– Designed specifically to replace depleting supply of WI-38 and MRC-5
1 Albert B Sabin, Peter K. Olitsky, Proceedings of the Society for Experimental Biology and medicine, Cultivation of Poliomyelitis
Virus in vitro in human embryonic tissue. Proc Soc Exp Biol Med 1936, 34:357-359
2 Joan C. Thicke, Darline Duncan, William Wood, A. E. Franklin and A. J. Rhodes; Cultivation of Poliomyelitis Virus in Tissue
Culture; Growth of the Lansing Strain in Human Embryonic Tissue, Canadian Journal of Medical Science, Vol. 30, pg 231-245
3 Thomas H. Weller, John F. Enders, Studies on the Cultivation of Poliomyelitis Viruses in Tissue Culture : I. The Propagation of
Poliomyelitis Viruses in Suspended Cell Cultures of Various Human Tissue; Journal of Immunology 1952;69;645-671
4 Plotkin et al, Attenuation of RA 2713 Rubella Virus in WI-38 Human Diploid Cell, American Journal of Diseases of Children, Vol.
118, pp 178-179, August 1969
5 T. H. Chang et al., “Chromosome Studies of Human Cells Infected in Utero and In Vitro with Rubella Virus,” Proceedings of the
Society for Experimental Biology and Medicine 122.1 (May 1966): 237–238
6 L. Hayflick and P.S. Moorhead, The Serial Cultivation of Human Diploid Cell Strains, Experimental Cell Research Vol 25, pp 585-
621, 1961
7 L. Hayflick, The Limited In Vitro Lifetime of Human Diploid Cell Strains, Experimental Cell Research, Vol 37, pp 614-636 1964
8 L. Hayflick, The Limited In Vitro Lifetime of Human Diploid Cell Strains, Experimental Cell Research, Vol 37, pp 614-636 1964
9 L. Hayflick, The Limited In Vitro Lifetime of Human Diploid Cell Strains, Experimental Cell Research, Vol 37, pp 614-636 1964
10 Plotkin et al, Cytological and Chromosomal Studies of Cell Strains from Aborted Human Fetuses, Exp Biology, Vol 122, 1966
11 Jacobs et al, Nature, Vol 227, pp 168 -170, 1970 Characteristics of a human diploid cell designated MRC-5.
12 https://wayback.archive-it.org/7993/20170404095417/https://www.fda.gov/ohrms/dockets/ac/01/transcripts/3750t1_01.pdf
13 https://cogforlife.org/wp-content/uploads/2012/05/imr90CoriellFullReport.pdf
14 https://grants.nih.gov/grants/guide/notice-files/not93-196.html
15 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC350439/pdf/pnas00499-0116.pdf
16 https://wayback.archive-it.org/7993/20170404095417/https://www.fda.gov/ohrms/dockets/ac/01/transcripts/3750t1_01.pdf
17 Walvax Biotechnology Co. Ltd.; Kunming, Yunnan, PR China Characteristics and viral propagation properties of a new human
diploid cell line, walvax-2, and its suitability as a candidate cell substrate for vaccine production, Apr 2015
